TMCnet News

Top 5 Reasons 67% of Couple Don't Try Invitro Fertilization (IVF): Results from The Stork Ib2C, Inc. Survey
[October 23, 2017]

Top 5 Reasons 67% of Couple Don't Try Invitro Fertilization (IVF): Results from The Stork Ib2C, Inc. Survey


An infographic is available on Business Wire's website and the Associated Press (News - Alert) photo network with results from The Stork OTC's 2017 "Journey to Conception" survey detailing the top five reasons why 67 percent of couples don't try Invitro Fertilization (IVF).

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171023005402/en/

The Stork OTC's 2017

The Stork OTC's 2017 "Journey to Conception" Survey Reveals that Women Want a Natural, Stress-Free, Inepensive Alternative to Clinical Fertility Treatments. Here is an infographic with the top five reasons 67 percent of couples don't try Invitro Fertilization (IVF). (Graphic: Business Wire)



About The Stork Ib2C, Inc., A Rinovum Women's Health Company:


Rinovum Women's Health is a privately held women's health company dedicated to bringing products to the market that will enhance women's lives and empower them to take charge of their health. The Stork Ib2C, Inc., A Rinovum Women's Health Company, launched its flagship product, The Stork® OTC, which is a conception device for reproductive health to assist in natural fertility and conception in the privacy of the patient's home. Rinovum Women's Health aims to support the development of products that are easy-to-use and safe, as well as a more economical way for a couple to address common fertility diagnoses. For more information about Rinovum Women's Health, The Stork Ib2C, Inc., and The Stork OTC visit www.rinovum.com and www.storkotc.com.


[ Back To TMCnet.com's Homepage ]